Singular Genomics Systems Inc (OMIC)
9.32
-1.78
(-16.04%)
USD |
NASDAQ |
Jun 27, 16:00
9.31
-0.01
(-0.11%)
After-Hours: 06:25
Singular Genomics Systems Research and Development Expense (TTM): 47.03M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 47.03M |
| December 31, 2023 | 47.76M |
| September 30, 2023 | 46.83M |
| June 30, 2023 | 48.35M |
| March 31, 2023 | 47.78M |
| December 31, 2022 | 46.20M |
| September 30, 2022 | 44.89M |
| Date | Value |
|---|---|
| June 30, 2022 | 41.07M |
| March 31, 2022 | 36.69M |
| December 31, 2021 | 32.66M |
| September 30, 2021 | 29.02M |
| June 30, 2021 | 26.19M |
| March 31, 2021 | 23.83M |
| December 31, 2020 | 21.25M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
21.25M
Minimum
Dec 2020
48.35M
Maximum
Jun 2023
38.54M
Average
42.98M
Median
Research and Development Expense (TTM) Benchmarks
| Bruker Corp | 307.60M |
| Azenta Inc | 35.10M |
| Harvard Bioscience Inc | 11.75M |
| Bionano Genomics Inc | 49.88M |
| Akoya Biosciences Inc | 21.67M |